The Cooper Companies, Inc. (NASDAQ:COO) Given Average Recommendation of “Moderate Buy” by Analysts

The Cooper Companies, Inc. (NASDAQ:COO) has been assigned an average recommendation of “Moderate Buy” from the thirteen analysts that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $115.00.

COO has been the topic of several recent research reports. Stifel Nicolaus restated a “buy” rating and set a $115.00 target price (up from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Piper Sandler raised their price objective on Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Wells Fargo & Company lifted their target price on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Morgan Stanley increased their price target on Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a report on Tuesday. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th.

Insider Transactions at Cooper Companies

In related news, CAO Agostino Ricupati sold 1,601 shares of Cooper Companies stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the sale, the chief accounting officer now owns 4,818 shares in the company, valued at approximately $520,488.54. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Cooper Companies news, COO Daniel G. Mcbride sold 114,992 shares of the company’s stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the sale, the chief operating officer now directly owns 44,696 shares in the company, valued at approximately $4,714,534.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CAO Agostino Ricupati sold 1,601 shares of the firm’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the transaction, the chief accounting officer now owns 4,818 shares in the company, valued at approximately $520,488.54. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 141,381 shares of company stock worth $14,927,361. Insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Franklin Resources Inc. raised its holdings in shares of Cooper Companies by 1.2% in the 4th quarter. Franklin Resources Inc. now owns 3,401 shares of the medical device company’s stock valued at $1,287,000 after purchasing an additional 41 shares in the last quarter. KLR Investment Advisors LLC raised its stake in Cooper Companies by 4.3% in the fourth quarter. KLR Investment Advisors LLC now owns 1,117 shares of the medical device company’s stock worth $423,000 after buying an additional 46 shares in the last quarter. Quadrant Capital Group LLC raised its stake in Cooper Companies by 10.8% in the fourth quarter. Quadrant Capital Group LLC now owns 613 shares of the medical device company’s stock worth $232,000 after buying an additional 60 shares in the last quarter. Westpac Banking Corp lifted its holdings in Cooper Companies by 18.8% during the fourth quarter. Westpac Banking Corp now owns 543 shares of the medical device company’s stock worth $205,000 after buying an additional 86 shares during the period. Finally, Lincoln National Corp boosted its position in Cooper Companies by 13.9% during the 4th quarter. Lincoln National Corp now owns 768 shares of the medical device company’s stock valued at $291,000 after acquiring an additional 94 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Performance

Shares of NASDAQ COO opened at $108.86 on Friday. Cooper Companies has a 52-week low of $75.93 and a 52-week high of $109.60. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99. The firm’s fifty day moving average is $95.10 and its two-hundred day moving average is $94.96. The company has a market cap of $21.68 billion, a P/E ratio of 64.04, a P/E/G ratio of 2.55 and a beta of 0.98.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The firm had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. During the same period in the prior year, the company earned $0.84 EPS. The company’s quarterly revenue was up 7.8% compared to the same quarter last year. As a group, analysts anticipate that Cooper Companies will post 3.66 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.